𝛼SK or Search

ENTITY

Nektar Therapeutics (NKTR US)

18

Analysis

Health Care • United States

Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms. The Company's product pipeline is comprised of early to late stage drug candidates across a number of therapeutic areas including oncology, pain, anti-infectives, anti-viral and immunology.

more

Refresh

Exchange Announcement • 01 Oct 2026 19:57

Current Report (Form 8-K | Period ending 2026-10-01)

Exchange Announcement • 25 Sep 2026 19:00

Current Report (Form 8-K | Period ending 2026-09-24)

Exchange Announcement • 09 Sep 2026 04:10

Current Report (Form 8-K | Period ending 2026-09-08)

Exchange Announcement • 13 Aug 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 06 Jun 2026 04:30

Current Report (Form 8-K | Period ending 2026-06-05)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x